MSB

2.51%

97.0¢ mesoblast limited

Novartis deal on the rocks, page-170

First 170 Last

Share
Profile

Follow
stocksa

7,911 Posts.

627

21/12/20

00:10

Post #: 49716575
Share

Originally posted by nippy ↑

Both items were said, maybe with slightly different words but both said all the same.

With so many new treatments before MSB got to try the trial design became invalid as to what was causing the data arising - be it good or bad. They also said the 43% was unlikely to be met.

What some have missed, maybe most have missed, is that this speeds up the process to :-

a) having a new trial aimed straight at the sweet spot by MSB and Novartis or

b) emergency approval when the secondary data is done and analysed on even a 5% to 20% improvement say or

c) both a and b occurring

People are also forgetting a 5% improvemet in mortality is 150 lives saved a day in the USA alone.

People are also forgetting other drugs/treatments have been approved despite only saving a few days on a hospital bed with no improvement in mortality at all.

It's all releative people - no 83% or 43% but almost certanly still way way way better than anything else being tried.

Expand

I must say MSB announcements take at least a week to decipher, mull and analyse before making any decision This would be my 4th that falls into this category

MSB Price at posting: $2.41 Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Is oil undervalued?

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

WGX

Westgold sets its sights on top five producer status through merger with Karora

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GRX

GreenX picks up prospective copper project in Germany

There are more pages in this discussion • 78 more messages in this thread...

First 170 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 97.0¢		Change -0.025(2.51%)		Mkt cap ! $1.107B

Open	High	Low	Value	Volume
97.0¢	$1.01	96.5¢	$7.757M	7.884M

Buyers (Bids)

No.	Vol.	Price($)
10	274918	97.0¢

Sellers (Offers)

Price($)	Vol.	No.
97.5¢	974	1

View Market Depth

No.	Vol.	Price($)
6	103162	0.970
5	34741	0.965
11	125566	0.960
1	500	0.955
22	165429	0.950

Price($)	Vol.	No.
0.975	974	1
0.990	10204	1
1.000	14000	1
1.010	2877	1
1.015	60000	1

Last trade - 16.10pm 02/08/2024 (20 minute delay)

MSB (ASX) Chart

Novartis deal on the rocks, page-170

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Venture to sniff out high-grade REE targets at Jupiter project, WA

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GreenX picks up prospective copper project in Germany

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Novartis deal on the rocks, page-170

Top Stories

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Venture to sniff out high-grade REE targets at Jupiter project, WA

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GreenX picks up prospective copper project in Germany

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News